Heron Therapeutics (HRTX) Profit After Tax (2010 - 2026)
Heron Therapeutics (HRTX) reported Profit After Tax of -$8.1 million for Q1 2026, down 407.82% on a YoY basis from $2.6 million in Q1 2025, and down 174.58% quarter-over-quarter from -$3.0 million in Q4 2025.
Heron Therapeutics (HRTX) Profit After Tax (2010 - 2026) Analysis & Trends
Heron Therapeutics has reported Profit After Tax for 17 years, with the latest figure at -$8.1 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax fell 407.82% year-over-year to -$8.1 million; the trailing twelve-month figure through Mar 2026 stood at -$30.9 million (down 297.44% YoY), and the FY2025 full-year result was -$20.2 million, down 48.71% from the prior year.
- Profit After Tax for Q1 2026 stood at -$8.1 million, down from -$3.0 million in the prior quarter.
- The five-year high for Profit After Tax was $3.7 million in Q4 2024, with the low at -$63.9 million in Q1 2022.
- Historically, Profit After Tax has averaged -$19.7 million across 5 years, with a median of -$10.7 million in 2023.
- Annual changes were most pronounced in 2025 — Profit After Tax jumped 183.39% — and 2026, when it slumped 407.82%.
- Heron Therapeutics' Profit After Tax stood at -$19.9 million in 2022, then jumped by 46.03% to -$10.7 million in 2023, then soared by 134.16% to $3.7 million in 2024, then sank by 180.64% to -$3.0 million in 2025, then slumped by 174.58% to -$8.1 million in 2026.
- The last three Profit After Tax figures came in at -$8.1 million (Q1 2026), -$3.0 million (Q4 2025), and -$17.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -56.74 Mn |
| 10 | Heron Therapeutics | 85.57 Mn | 55.60 Mn | 24.07 Mn | -8.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.11 Mn |
| Dec 31, 2025 | -2.95 Mn |
| Sep 30, 2025 | -17.50 Mn |
| Jun 30, 2025 | -2.38 Mn |
| Mar 31, 2025 | 2.64 Mn |
| Dec 31, 2024 | 3.66 Mn |
| Sep 30, 2024 | -4.85 Mn |
| Jun 30, 2024 | -9.24 Mn |
| Mar 31, 2024 | -3.16 Mn |
| Dec 31, 2023 | -10.72 Mn |
| Sep 30, 2023 | -25.01 Mn |
| Jun 30, 2023 | -42.06 Mn |
| Mar 31, 2023 | -32.77 Mn |
| Dec 31, 2022 | -19.87 Mn |
| Sep 30, 2022 | -41.91 Mn |
| Jun 30, 2022 | -56.36 Mn |
| Mar 31, 2022 | -63.89 Mn |
| Dec 31, 2021 | -54.65 Mn |
| Sep 30, 2021 | -52.41 Mn |
| Jun 30, 2021 | -61.02 Mn |